Director, Value Evidence
AESARA
Chapel hill, NC
Dan Gratie is a Director within the Value Evidence at AESARA, a value and access consulting agency.
As a consultant, Dan has partnered with industry clients to conduct comprehensive competitive landscape analyses, develop and improve payer-facing communication tools, and evaluate and creatively address potential evidence gaps in a variety of therapeutic areas, including oncology and other specialty products. Additionally, Dan draws on experiences across the product life cycle, from pipeline to post-launch positioning in the face of upcoming competitors.
Prior to joining AESARA, Dan was a Clinical Health Outcomes fellow at GlaxoSmithKline (GSK) and the University of North Carolina (UNC) after completing his PharmD. At GSK he gained experience developing evidence generation protocols, managing ongoing studies, creating communications, and contributing to value dossiers for GSK’s respiratory portfolio.
(R3) Research Podium Session – Leveraging Real-World Data to Advance Managed Care Pharmacy Practice
Tuesday, October 15, 2024
3:30 PM – 4:45 PM PT